Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
Capricor Therapeutics (CAPR) Stock Price & Analysis
577 Followers
CAPR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.30 - $6.58
Previous Close$4.69
Volume30.14K
Average Volume (3M)65.77K
Market Cap
$120.66M
Enterprise Value$79.11M
Total Cash (Recent Filing)$45.17M
Total Debt (Recent Filing)$5.77M
Price to Earnings (P/E)-4.0
Beta0.66
Next Earnings
Aug 10, 2023EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.17
Shares Outstanding25,269,926
10 Day Avg. Volume63,397
30 Day Avg. Volume65,774
Standard Deviation0.68
R-Squared0.10
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)96.58
Price to Sales (P/S)39.68
Price to Cash Flow (P/CF)6.90
P/FCF Ratio6.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue14.29
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.76
Forecast
1Y Price Target
$15.00Price Target Upside214.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Capricor Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CAPR FAQ
What was Capricor Therapeutics’s price range in the past 12 months?
Capricor Therapeutics lowest stock price was $3.30 and its highest was $6.58 in the past 12 months.
What is Capricor Therapeutics’s market cap?
Currently, no data Available
When is Capricor Therapeutics’s upcoming earnings report date?
Capricor Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 63 days.
How were Capricor Therapeutics’s earnings last quarter?
Capricor Therapeutics released its earnings results on May 11, 2023. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.32 by $0.01.
Is Capricor Therapeutics overvalued?
According to Wall Street analysts Capricor Therapeutics’s price is currently Undervalued.
Does Capricor Therapeutics pay dividends?
Capricor Therapeutics does not currently pay dividends.
What is Capricor Therapeutics’s EPS estimate?
Capricor Therapeutics’s EPS estimate is -$0.35.
How many shares outstanding does Capricor Therapeutics have?
Capricor Therapeutics has 25,269,926 shares outstanding.
What happened to Capricor Therapeutics’s price movement after its last earnings report?
Capricor Therapeutics reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.32. Following the earnings report the stock price went down -1.946%.
Which hedge fund is a major shareholder of Capricor Therapeutics?
Among the largest hedge funds holding Capricor Therapeutics’s share is Oracle Investment Management Inc. It holds Capricor Therapeutics’s shares valued at N/A.
---
Capricor Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (214.14% Upside)
$15.00 (214.14% Upside)
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $949.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
31.37%
12-Months-Change
Fundamentals
Return on Equity
-187.82%
Trailing 12-Months
Asset Growth
-17.03%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Capricor Therapeutics
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA.
---
Top 5 ETFs holding CAPR
iShares Core S&P Total U.S. Stock Market ETF
$415.88K
Up to five ETFs with an Outperform Smart Score that hold CAPR. The ETFs are listed according to market value of CAPR within the ETF
---
---